Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Tehran University of Medical Sciences

Iran · Middle East

#944World rank of 1,038
25.5ICI scoreout of 100
#1National rank, of 5 in Iran
#10Regional rank, of 20 in Middle East
163Verified industry works, 2021 to 2025
81Company groups worked with (28 on two or more works)

Tehran University of Medical Sciences is ranked #944 of 1,038. Its strongest pillar is breadth (71): partners spread across many research fields. It is held back most by co-creation (0): 163 verified industry works against about 1,540 expected for its mix of fields; and by scale (11): a network of 28 company groups on two or more joint works.

Research Collaboration Index 2026: #520 of 1,195, Silver standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
0

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 163 verified works against about 1,540 expected for its fields (0.11 times the expected rate).

Durability20% of the score
39

How much of its industry work sits in sustained partnerships with the same company group. 6 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
11

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 28 company groups on two or more joint works; 6 sustained partnerships.

Breadth20% of the score
71

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (25.5) is the weighted average of the four percentiles. Rank 944 of 1,038 overall; 1 of 5 in Iran; 10 of 20 in Middle East. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

0.4%of its 36,771 research works in 2021 to 2025 were co-authored with a verified company
0.11Industry co-authorship rate: 0.11 times what its mix of research fields would predict (163 verified works; about 1,540 expected)
6sustained partnerships: the same company group on five or more joint works in three or more of the five years

In Iran

1 of 5 ranked universities in Iran

  1. #1 Tehran University of Medical Sciences world #944, score 25.5
  2. #2 Islamic Azad University, Tehran world #996, score 20.5
  3. #3 Shahid Beheshti University of Medical Sciences world #1002, score 19.5
  4. #4 University of Tehran world #1019, score 16.8
  5. #5 Amirkabir University of Technology world #1030, score 14.2

All ranked universities →   Middle East: 10 of 20 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Not yet ranked in any sector: a sector ranking needs at least 20 verified works in the sector. Its largest sector is Pharmaceuticals and Therapeutics, with 19.

Pharmaceuticals and Therapeutics
19under 20 works
Medical Technology and Digital Health
6under 20 works
Advanced Materials and Nanotechnology
4.5under 20 works
Biotechnology and Advanced Therapies
3under 20 works
Climate, Environment and Sustainability
3under 20 works
Agriculture and Food Technology
2under 20 works
Artificial Intelligence
1under 20 works
Not in any of the 21 sectors
124.5counted in the overall index

38.5 of its 163 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Tehran University of Medical Sciences co-authored verified work with 81 company groups, consortium papers aside: 28 of them on two or more works, and 6 as sustained partners.

The largest 12 of its 81 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
CinnaGenIranMedicine185 of 5
CentogeneGermanyBiochemistry, Genetics and Molecular Biology94 of 5
Abt AssociatesNepalEconomics, Econometrics and Finance83 of 5
National Iranian Oil CompanySTATE-OWNEDIranEngineering83 of 5
Orchid PharmaIndiaChemistry7.54 of 5
Nordic BioscienceDenmarkMedicine64 of 5
Iran KhodroIranEngineering44 of 5
Connecting Health InnovationsUnited StatesMedicine44 of 5
NestléSwitzerlandMedicine32 of 5
BASFGermanyMaterials Science32 of 5
UltromicsUnited KingdomMedicine32 of 5

1 further partner group is not named here because the open record gives an address, a person's name or other text in place of an organisation's name; its joint works still count in every figure on this page.

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Over time

Verified industry works by year

352021
362022
312023
322024
292025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

1 industry-partnered clinical trial

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

The trial:

  • NCT04653493 CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) with Sabz Biomedicals, 2021

Funded partnerships (reported, not scored)

Publicly funded research projects with companies

European Union: 1 Horizon projects with company partners

Horizon 2020 and Horizon Europe projects starting 2021-2025 in which this university and at least one company take part (2 distinct companies). Company partners include: In-jet ApS, Labman Automation Limited.

  • PoCCardio Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio) 2023, 2 companies

Shown for context from the public grant registries; they do not enter the score in Edition 1. Comparable open registries of company partners exist for the European Union and the United Kingdom but not yet for most other research systems, and in some countries national research organisations take part on behalf of university laboratories, so these counts are not comparable between countries.

Evidence checked

204 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 552 of 756 candidate links were set aside.

Why links were set aside
  • 245 company name not written in the author's affiliation
  • 88 excluded after hand audit: Razi Institute is a government research institute
  • 72 ordinary-word name without a company suffix
  • 66 part of a university or public institute's own unit
  • 16 not an industry organisation
  • 11 a place or common word that failed its stricter rule
  • 54 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

GRP Partnership Intelligence Platform

Where Tehran University of Medical Sciences's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Tehran University of Medical Sciences ranks #520 of 1,195, with Silver standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.